Please note, Alexar has changed its name to Ralexar

News

Monthly Archives

May 2017
March 2016
November 2015
January 2015
January 2014

Yearly Archives

2017
2016
2015
2014

News

2015 yearly archives

Alexar Therapeutics, Inc. Initiates Phase IIa Clinical Trial for ALX-101 Topical Gel | Nov 23, 2015

Study to Assess Novel Liver X Receptor (LXR) Agonist for the Treatment of Patients with Atopic Dermatitis MALVERN, Pa., Nov …

Alexar Awarded Michael J. Fox Foundation Grant for Research on a Novel Parkinson’s Disease Therapeutic | Jan 23, 2015

Alexar Therapeutics, Inc. announced today that it has been awarded a preclinical research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop Liver X Receptor (LXR) agonists for the treatment of Parkinson’s disease

Web Design & Development time4design - Bucks County Web Design.